Parameters

•Download as PPTX, PDF•

0 likes•798 views

This document discusses analytes and their normal ranges. It was written by Dr. Rittu Chandel, who is an Assistant Professor at the GMC (Government Medical College) in Nanded, India. The document focuses on providing reference values for various analytes that are commonly tested in clinical settings.

Analytes- normal ranges
Dr.Rittu Chandel
Ast Prof
GMC,NANDED

Viewers also liked

Cellular respiration in detailpcalabri

ISOENZYMES & CLINICAL ENZYMOLOGY

YESANNA

Enzymes. classification. isoenzymesLSMU-Lugansk State Medical university

Neuromuscular junctionVarnaka CH

Metabolism- BiochemistryBurhan Umer

Clinical Enzymology

Namrata Chhabra

Enzyme and coenzyme

Heru Pramono

A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...SlideShare

2015 Upload Campaigns Calendar - SlideShare

SlideShare

What to Upload to SlideShare

SlideShare

How to Make Awesome SlideShares: Tips & Tricks

SlideShare

Getting Started With SlideShare

SlideShare

Viewers also liked (12)

Cellular respiration in detail

ISOENZYMES & CLINICAL ENZYMOLOGY

Enzymes. classification. isoenzymes

Neuromuscular junction

Metabolism- Biochemistry

Clinical Enzymology

Enzyme and coenzyme

A Guide to SlideShare Analytics - Excerpts from Hubspot's Step by Step Guide ...

2015 Upload Campaigns Calendar - SlideShare

What to Upload to SlideShare

How to Make Awesome SlideShares: Tips & Tricks

Getting Started With SlideShare

Recently uploaded

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf

Jim Jacob Roy

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Prof. Marcus Renato de Carvalho

Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva. Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade. Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal. Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural. Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis. É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais. O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada. Recomendamos muito. Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos. Esta publicação só está disponível em inglês até o momento. Prof. Marcus Renato de Carvalho www.agostodourado.com

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

FFragrant

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo - Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Dr. Vinay Pareek

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

planning for change nursing Management ppt

Thangamjayarani

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Krishan Murari

Are There Any Natural Remedies To Treat Syphilis.pdf

Little Cross Family Clinic

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

Sex determination from mandible pelvis and skull

ShashankRoodkee

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Anujkumaranit

Recently uploaded (20)

MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx

Ophthalmology Clinical Tests for OSCE exam

micro teaching on communication m.sc nursing.pdf

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

planning for change nursing Management ppt

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Are There Any Natural Remedies To Treat Syphilis.pdf

New Drug Discovery and Development .....

Sex determination from mandible pelvis and skull

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Parameters

1. Analytes- normal ranges Dr.Rittu Chandel Ast Prof GMC,NANDED

Parameters

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (12)

More from Dr.Rittu Chandel MBBS, MD

More from Dr.Rittu Chandel MBBS, MD (17)

Recently uploaded

Recently uploaded (20)

Parameters